Longevity.haus
IFCOR laboratory technician performing sample analysis with pipette
Two IFCOR scientists reviewing samples at microscope
IFCOR laboratory technician with pipette — close-up

Thyroid Comprehensive Panel (TSH + fT4 + fT3 + Antibodies)

Type

Thyroid Panel

Duration

15 min

Results

24 hours

Sample

Blood (venous draw)

What's included

7 deliverables in this treatment

  • TSH (thyroid-stimulating hormone)
  • Free T4 (thyroxine) and free T3 (triiodothyronine — active form)
  • Anti-TPO antibodies — Hashimoto's and Graves' disease marker
  • Anti-TG (anti-thyroglobulin) antibodies — autoimmune complement
  • Thyroglobulin — thyroid cancer follow-up marker
  • Phlebotomy included
  • Results by secure email next business day

The Thyroid Comprehensive panel extends the Basic two-marker screen with four additional markers — free T3, anti-TPO, anti-TG, and thyroglobulin — that are necessary to diagnose autoimmune thyroid disease (Hashimoto's thyroiditis, Graves' disease), distinguish thyroid cancer recurrence monitoring, and assess T3/T4 conversion efficiency. Free T3 is the biologically active form of thyroid hormone; its ratio to T4 reveals conversion problems in peripheral tissues. Anti-TPO and anti-TG antibodies are the hallmarks of autoimmune thyroid disease, present in over 90% of Hashimoto's cases. This panel is the appropriate choice when the Basic screen returns borderline results or when autoimmune thyroid disease is suspected.

About this treatment

The Thyroid Comprehensive panel at IFCOR Jihlava provides the complete picture needed to diagnose, classify, and monitor thyroid pathology beyond the capabilities of the Basic two-marker screen. Free T3 (triiodothyronine, the biologically active form) is produced partly by the thyroid and partly by peripheral conversion from T4 in the liver, kidneys, and other tissues. Measuring fT3 alongside fT4 reveals T3/T4 conversion efficiency, which can be impaired…

Good to know

Markers
TSH, fT4, fT3, anti-TPO, anti-TG, thyroglobulin
Diagnoses
Hashimoto's, Graves', T3/T4 conversion issues, cancer monitoring
Turnaround
Next business day
Accreditation
ISO 15189:2013 (ČIA M 8106)

Who is this for?

Individuals with suspected autoimmune thyroid disease (Hashimoto's, Graves'), borderline TSH/T4 results, persistent hypothyroid symptoms despite normal TSH, or post-thyroidectomy cancer monitoring.

Preparation required

Fasting preferred. Morning collection recommended. Inform staff of any thyroid medications — do not omit levothyroxine doses unless your physician specifically instructs.

About the clinic

Reviews, team and credentials

Independent review links and clinic-reported team information.

Clinical team

IFCOR was founded and is led by RNDr. František Flek, who established the original allergy and immunology laboratory in 1994. The network holds ISO 15189:2013 accreditation across five facilities (ČIA number M 8106) and participates in four external quality assurance programmes: SEKK, EHK SZÚ Prague, Instand, and ÚHKT. The Jihlava laboratory team covers nine specialist disciplines — clinical biochemistry,…

Clinic-reported credentials

ISO 15189:2013 (ČIA M 8106) SÚKL diagnostic laboratory permit SZÚ sterilizer control authorisation SEKK external quality assurance EHK SZÚ Prague external quality assurance Instand external quality assurance ÚHKT external quality assurance

Languages: Czech

View the full IFCOR – Klinické laboratoře profile
Compare Thyroid Panel in Czechia →